These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8728200)

  • 21. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients.
    Gao H; Lew SQ; Bosch JP
    Am J Nephrol; 1999; 19(1):7-12. PubMed ID: 10085443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed children.
    Besbas N; Ozaltin F; Coşkun T; Ozalp S; Saatçi U; Bakkaloğlu A; El Nahas AM
    Pediatr Nephrol; 2003 Dec; 18(12):1255-9. PubMed ID: 14586683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis.
    Misra M; Reaveley DA; Ashworth J; Muller B; Seed M; Brown EA
    Perit Dial Int; 1997; 17(3):279-86. PubMed ID: 9237290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibronectin in patients with chronic renal failure undergoing dialysis.
    Hou FF; Zhang X; Wang AL; Wu JG
    Nephron; 1990; 55(1):45-8. PubMed ID: 2352577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins.
    Kagan A; Bar-Khayim Y; Schafer Z; Fainaru M
    Nephron; 1993; 63(1):32-42. PubMed ID: 8446249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting low values of serum albumin in CAPD patients.
    Han DS; Lee SW; Kang SW; Choi KH; Lee HY; Cho EY; Lee JH
    Adv Perit Dial; 1996; 12():288-92. PubMed ID: 8865921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of residual renal function on quality of life in patients with peritoneal dialysis
.
    Zhou W; Hu W; Han G; Wang H; Zhang J; Mei C
    Clin Nephrol; 2018 Aug; 90(2):106-111. PubMed ID: 29932407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Continuous ambulatory peritoneal dialysis. An alternative to hemodialysis].
    Groth H; Steurer J; Spuler A; Streuli RA; Kuhlmann U
    Schweiz Rundsch Med Prax; 1984 Dec; 73(51-52):1569-75. PubMed ID: 6522902
    [No Abstract]   [Full Text] [Related]  

  • 31. Nutrition indices in obese continuous peritoneal dialysis patients with inadequate and adequate urea clearance.
    Tzamaloukas AH; Servilla KS; Murata GH; Hoffman RM
    Perit Dial Int; 2002; 22(4):506-12. PubMed ID: 12322823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic ambulatory peritoneal dialysis].
    Glasson P; Leski M; Favre H
    Schweiz Med Wochenschr; 1981 Aug; 111(34):1232-8. PubMed ID: 7025196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous ambulatory peritoneal dialysis - initial experience.
    Watson AJ; Hillery M; Grant G; Stassen LF; Keogh JA
    Ir Med J; 1981 Nov; 74(11):330-3. PubMed ID: 7309459
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipoprotein (a) levels in patients undergoing continuous ambulatory peritoneal dialysis.
    Guindeo C; Vega N; Fernandez AM; Palop L; Aguilar JA; Moreda A; Cia P
    Perit Dial Int; 1996; 16 Suppl 1():S236-40. PubMed ID: 8728199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining adequacy of CAPD with urea kinetics.
    Keshaviah PR; Nolph KD; Prowant B; Moore H; Ponferrada L; Van Stone J; Twardowski ZJ; Khanna R
    Adv Perit Dial; 1990; 6():173-7. PubMed ID: 1982802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the methods used to determine dialysis adequacy in CAPD patients.
    Ateş K; Ertürk S; Nergisoğlu G; Karatan O; Duman N; Erbay B; Ertuğ AE
    Nephrol Dial Transplant; 1996 Oct; 11(10):2108-9. PubMed ID: 8918740
    [No Abstract]   [Full Text] [Related]  

  • 37. New prescription of peritoneal dialysis: intermittent ambulatory peritoneal dialysis.
    Okada K; Urae J; Takahashi S
    Nephron; 1996; 74(2):459-61. PubMed ID: 8893188
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of nutritional status in continuous ambulatory peritoneal dialysis patients: a comparison of bioelectric impedance and conventional methods.
    Cheng CH; Chen MY; Lee YJ; Lee MC; Shu KH; Wu MY; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):758-64. PubMed ID: 11076433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein (a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.
    Webb AT; Reaveley DA; O'Donnell M; O'Connor B; Seed M; Brown EA
    Nephrol Dial Transplant; 1993; 8(7):609-13. PubMed ID: 8396744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
    Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
    J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.